Clinical Trial: A Study to Evaluate the Bioequivalence Between Immediate Release Tablets and Minitablets of Deucravacitinib (BMS-986165), and the Effect of Food and pH on the Drug Levels of the Minitablets in Healthy Adults

U.S., March 1 -- ClinicalTrials.gov registry received information related to the study (NCT06851871) titled 'A Study to Evaluate the Bioequivalence Between Immediate Release Tablets and Minitablets of Deucravacitinib (BMS-986165), and the Effect of Food and pH on the Drug Levels of the Minitablets in Healthy Adults' on Jan. 22.

Brief Summary: The purpose of this study is to evaluate the bioequivalence between immediate release tablets and minitablets of Deucravacitinib (BMS-986165), and the effect of food and pH on the drug levels of the minitablets in healthy adults.

Study Start Date: Jan. 23

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: Deucravacitinib

Specified dose on specified days

DRUG: Famoti...